High BMI-attributable hypertensive heart disease deaths globally increased by approximately 148% (relative change 1.48) from 1990 to 2021, with disproportionately higher mortality in females.
Observational
Sí
The global burden of hypertensive heart disease attributable to high BMI has increased by approximately 148% from 1990 to 2021, disproportionately affecting females and low-resource regions.
Estimación del efecto: Relative change 1.48
In order to provide insights crucial for achieving UN Sustainable Development Goal 3.4, this study attempts to evaluate the global burden of hypertensive heart disease (HHD) owing to high BMI, stratified by gender and SDI, from 1990 to 2021 and projects trends to 2051. Leveraging Global Burden of Disease 2021 data, we assessed HHD mortality and DALYs attributable to high BMI via DisMod-MR 2.1. Health inequalities were quantified using SII and CI, with Bayesian age-period-cohort modeling enabling gender-stratified projections. Global HHD deaths attributable to high BMI showed a relative change of 1.48 from 1990-2021, corresponding to an approximately 148% increase. Females experienced disproportionately higher mortality (relative change +1.4) and DALYs (relative change +1.12) than males. Southern sub-Saharan Africa recorded the steepest ASMR increase (relative change +0.54), while East Asia saw mortality surge (relative change +1.14). The escalating HHD burden from high BMI is a health inequality crisis, disproportionately affecting females and low-resource regions. This demands urgent tiered interventions and requires reconciling economic growth with health system resilience to address the underlying socioeconomic paradox.
Zhou et al. (Thu,) conducted a observational in Hypertensive heart disease attributable to high BMI. High BMI was evaluated on Hypertensive heart disease deaths attributable to high BMI (Relative change 1.48). High BMI-attributable hypertensive heart disease deaths globally increased by approximately 148% (relative change 1.48) from 1990 to 2021, with disproportionately higher mortality in females.